- Download as Adobe PDF
Rights statement: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Final published version, 1 MB, PDF-document
Licence: Creative Commons: Attribution (CC-BY)
| Original language | English |
|---|
| Journal | Thorax |
|---|
| Early online date | 24 Mar 2018 |
|---|
| DOIs | |
|---|
| Publication status | E-pub ahead of print - 24 Mar 2018 |
|---|
Acute lung injury (ALI) is neutrophil-dominant, life-threatening disease without effective therapies and better understanding of the pathophysiological mechanisms involved is an urgent need. Here we show that IL-22 is produced from innate lymphoid cells (ILCs) and is responsible for suppression of experimental lung neutrophilic inflammation. Blocking prostaglandin E2 (PGE2) synthesis reduces lung ILCs and IL-22 production, resulting in exacerbation of lung neutrophilic inflammation. In contrast, activation of the PGE2 receptor EP4 prevents acute lung inflammation. We thus demonstrate a mechanism for production of innate IL-22 in the lung during acute injury, highlighting potential therapeutic strategies for control of lung neutrophilic inflammation by targeting the PGE2/ILC/IL-22 axis.
ID: 54253473
